Loss-of-function pathogenic variants in EPM2A or EPM2B lead to an accumulation of Lafora bodies (an abnormal form of glycogen that cannot be metabolized) and subsequent Lafora disease (47). This evidence concerns the gene NHLRC1 and Lafora disease.